<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Merle JL</submitter><funding>Clinical and Translational Sciences Awards</funding><funding>NCATS NIH HHS</funding><funding>U.S. National Library of Medicine</funding><funding>Clinical and Translational Science Awards</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>41</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12934111</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>The Clinical Sustainability Assessment Tool (CSAT) is designed to capture determinants of sustainable clinical practices over time. Although the full 49-item CSAT instrument has demonstrated strong psychometric properties, the 21-item short form has had limited evaluation. This study aimed to assess the CSAT short form (CSAT Short) across different respondent characteristics and care delivery settings.&lt;h4>Methods&lt;/h4>We evaluated the CSAT Short in a sample of healthcare personnel (N = 256 respondents) drawn from across three hybrid effectiveness-implementation studies in a research consortium, all of which tested routine symptom surveillance and integration of symptom management interventions in ambulatory oncology care settings in the US. Confirmatory factor analyses (CF</pubmed_abstract><journal>Implementation science communications</journal><pubmed_title>Psychometric properties of the Clinical Sustainability Assessment Tool (CSAT) short form across three research centers evaluating effectiveness and implementation of a cancer symptom surveillance and management intervention.</pubmed_title><pmcid>PMC12934111</pmcid><funding_grant_id>T15LM007124</funding_grant_id><funding_grant_id>UM1CA233080</funding_grant_id><funding_grant_id>UL1 TR001422</funding_grant_id><funding_grant_id>UL1TR002541</funding_grant_id><funding_grant_id>UL1TR002377</funding_grant_id><funding_grant_id>UM1CA233033</funding_grant_id><funding_grant_id>UM1CA233035</funding_grant_id><funding_grant_id>U24CA232980</funding_grant_id><pubmed_authors>Griffin J</pubmed_authors><pubmed_authors>Mitchell SA</pubmed_authors><pubmed_authors>O'Connor M</pubmed_authors><pubmed_authors>Herrin J</pubmed_authors><pubmed_authors>Paudel R</pubmed_authors><pubmed_authors>McCleary NJ</pubmed_authors><pubmed_authors>IMPACT Consortium</pubmed_authors><pubmed_authors>Mai QH</pubmed_authors><pubmed_authors>Ahrens P</pubmed_authors><pubmed_authors>Yanez B</pubmed_authors><pubmed_authors>Wehbe F</pubmed_authors><pubmed_authors>Bian JJ</pubmed_authors><pubmed_authors>Uno H</pubmed_authors><pubmed_authors>Poirier-Shelton T</pubmed_authors><pubmed_authors>Austin JD</pubmed_authors><pubmed_authors>Coughlin A</pubmed_authors><pubmed_authors>Dizon DS</pubmed_authors><pubmed_authors>Cronin C</pubmed_authors><pubmed_authors>Hemming K</pubmed_authors><pubmed_authors>Richardson J</pubmed_authors><pubmed_authors>Kroner BL</pubmed_authors><pubmed_authors>Garcia S</pubmed_authors><pubmed_authors>Richardson K</pubmed_authors><pubmed_authors>Garcia M</pubmed_authors><pubmed_authors>Mallow J</pubmed_authors><pubmed_authors>Schrag D</pubmed_authors><pubmed_authors>Rahman P</pubmed_authors><pubmed_authors>Hodgdon C</pubmed_authors><pubmed_authors>Tyndall BD</pubmed_authors><pubmed_authors>Osarogiagbon RU</pubmed_authors><pubmed_authors>Cella D</pubmed_authors><pubmed_authors>Caron K</pubmed_authors><pubmed_authors>Faris N</pubmed_authors><pubmed_authors>Redmond S</pubmed_authors><pubmed_authors>Tesch N</pubmed_authors><pubmed_authors>Bass M</pubmed_authors><pubmed_authors>Ardini MA</pubmed_authors><pubmed_authors>Popovic J</pubmed_authors><pubmed_authors>Kroenke K</pubmed_authors><pubmed_authors>Tofthagen C</pubmed_authors><pubmed_authors>Begnoche M</pubmed_authors><pubmed_authors>Reich J</pubmed_authors><pubmed_authors>Wong SL</pubmed_authors><pubmed_authors>Podratz J</pubmed_authors><pubmed_authors>Tasker L</pubmed_authors><pubmed_authors>Cahue S</pubmed_authors><pubmed_authors>Smith AW</pubmed_authors><pubmed_authors>Penedo F</pubmed_authors><pubmed_authors>Tramontano A</pubmed_authors><pubmed_authors>Jensen R</pubmed_authors><pubmed_authors>Smith JD</pubmed_authors><pubmed_authors>Flores AM</pubmed_authors><pubmed_authors>DiMartino L</pubmed_authors><pubmed_authors>Weiner B</pubmed_authors><pubmed_authors>Lancki N</pubmed_authors><pubmed_authors>Hazard-Jenkins HW</pubmed_authors><pubmed_authors>Preiss L</pubmed_authors><pubmed_authors>Hassett MJ</pubmed_authors><pubmed_authors>Schaepe K</pubmed_authors><pubmed_authors>Pachman D</pubmed_authors><pubmed_authors>Cheville AL</pubmed_authors><pubmed_authors>Kuharic M</pubmed_authors><pubmed_authors>Norton WE</pubmed_authors><pubmed_authors>Lam V</pubmed_authors><pubmed_authors>Silberman P</pubmed_authors><pubmed_authors>Dias S</pubmed_authors><pubmed_authors>Merle JL</pubmed_authors><pubmed_authors>Ridgeway JL</pubmed_authors><pubmed_authors>Ruddy K</pubmed_authors><pubmed_authors>Chlan L</pubmed_authors><pubmed_authors>Simpson J</pubmed_authors><pubmed_authors>Kircher S</pubmed_authors><pubmed_authors>Pearson L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Psychometric properties of the Clinical Sustainability Assessment Tool (CSAT) short form across three research centers evaluating effectiveness and implementation of a cancer symptom surveillance and management intervention.</name><description>&lt;h4>Objective&lt;/h4>The Clinical Sustainability Assessment Tool (CSAT) is designed to capture determinants of sustainable clinical practices over time. Although the full 49-item CSAT instrument has demonstrated strong psychometric properties, the 21-item short form has had limited evaluation. This study aimed to assess the CSAT short form (CSAT Short) across different respondent characteristics and care delivery settings.&lt;h4>Methods&lt;/h4>We evaluated the CSAT Short in a sample of healthcare personnel (N = 256 respondents) drawn from across three hybrid effectiveness-implementation studies in a research consortium, all of which tested routine symptom surveillance and integration of symptom management interventions in ambulatory oncology care settings in the US. Confirmatory factor analyses (CF</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T21:36:30.479Z</modification><creation>2026-07-10T03:15:26.97Z</creation></dates><accession>S-EPMC12934111</accession><cross_references><pubmed>41612516</pubmed><doi>10.1186/s43058-026-00867-5</doi></cross_references></HashMap>